SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-031567
Filing Date
2021-05-11
Accepted
2021-05-11 14:56:18
Documents
2
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7865
2 EX-24 DOCUMENT attachment1.htm EX-24 3798
  Complete submission text file 0001209191-21-031567.txt   12989
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Todisco Joseph (Reporting) CIK: 0001774807 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 21910883